John Tucker
Chief Executive Officer chez SCPHARMACEUTICALS INC.
Fortune : 1 M $ au 31/03/2024
Profil
John H.
Tucker is currently the President, Chief Executive Officer & Director at scPharmaceuticals, Inc. and a Director at Eleusis Holdings Ltd.
He previously served as the President, Chief Executive Officer & Treasurer at ASC Liquidation Corp., the Chief Executive Officer & Director at Alcresta Therapeutics, Inc., the Chief Executive Officer-North American Business at Nelson Bach Usa Ltd., the Executive Vice President-Sales & Marketing at Indevus Pharmaceuticals, Inc., the Chief Commercial Officer & Senior Vice President at Incline Therapeutics, Inc., the Senior Vice President-Commercial Operations at AMAG Pharmaceuticals, Inc., and the President-US Operations at Basilea Pharmaceuticals Ltd.
Mr. Tucker received an undergraduate degree from Plymouth State University and an MBA from Southern New Hampshire University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCPHARMACEUTICALS, INC.
0,71% | 29/03/2024 | 254 207 ( 0,71% ) | 1 M $ | 31/03/2024 |
Postes actifs de John Tucker
| Sociétés | Poste | Début |
|---|---|---|
| SCPHARMACEUTICALS INC. | Chief Executive Officer | 01/01/2017 |
Anciens postes connus de John Tucker
| Sociétés | Poste | Fin |
|---|---|---|
Eleusis Holdings Ltd.
 Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The private company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Director/Board Member | 01/10/2022 |
ASC Liquidation Corp.
 ASC Liquidation Corp. Environmental ServicesIndustrial Services ASC Liquidation Corp. provided wastewater management services. It produced beta-glucan for animal feed to improve immune system. The company was founded by John Rice, Jeffrey Lebrun, Robert Levine, and Geoffrey Paul Horst on June 12, 2009 and was headquartered in Plymouth, MI. | Chief Executive Officer | 01/01/2017 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Chief Executive Officer | 01/07/2016 |
Nelson Bach Usa Ltd.
 Nelson Bach Usa Ltd. Pharmaceuticals: OtherHealth Technology Nelson Bach Usa Ltd. is based in North Andover. Nelson Bach USA Ltd. is a leading manufacturer of natural healthcare products with an impressive portfolio. The company is the home of Nelsons, which has been trusted by generations worldwide for over 85 years to provide families with natural healthcare products. Nelsons has been in operation since 1860. | Corporate Officer/Principal | 01/04/2014 |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Corporate Officer/Principal | 01/01/2013 |
Formation de John Tucker
| Plymouth State University | Undergraduate Degree |
| Southern New Hampshire University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCPHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
ASC Liquidation Corp.
ASC Liquidation Corp. Environmental ServicesIndustrial Services ASC Liquidation Corp. provided wastewater management services. It produced beta-glucan for animal feed to improve immune system. The company was founded by John Rice, Jeffrey Lebrun, Robert Levine, and Geoffrey Paul Horst on June 12, 2009 and was headquartered in Plymouth, MI. | Industrial Services |
Incline Therapeutics, Inc.
Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
Basilea Pharmaceuticals Ltd.
 Basilea Pharmaceuticals Ltd. Medical DistributorsDistribution Services Part of Basilea Pharmaceutica AG, Basilea Pharmaceuticals Ltd. distributes pharmaceutical products. The private company is based in Rickmansworth, UK. Founded in 2007. | Distribution Services |
Nelson Bach Usa Ltd.
Nelson Bach Usa Ltd. Pharmaceuticals: OtherHealth Technology Nelson Bach Usa Ltd. is based in North Andover. Nelson Bach USA Ltd. is a leading manufacturer of natural healthcare products with an impressive portfolio. The company is the home of Nelsons, which has been trusted by generations worldwide for over 85 years to provide families with natural healthcare products. Nelsons has been in operation since 1860. | Health Technology |
Eleusis Holdings Ltd.
Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The private company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Commercial Services |
